Clinical trial
Tamoxifen Resistance in Breast Cancer
NCT00899197 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tamoxifen Resistance in Breast Cancer
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 31, 2007
- Completion date
- June 30, 2012
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer